Risk of Bleeding and Thromboembolic Events in Newly Treated Nonvalvular Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists: A French Nationwide Propensity-Matched Cohort Study
Circulation 2015 Jul 21;[EPub Ahead of Print], G Maura, PO Blotière, K Bouillon, C Billionnet, P Ricordeau, F Alla, M ZureikFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.